Showing results (1321-1330 of 1,717) with videos related to

Sort By:
Pageof 172
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
Annals of Surgery|July 7, 2022
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesTimothy E Newhook, Michael J Overman, Yun Shin Chun, et al.
Cell Death and Differentiation|April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteinsJia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
Clinical and Translational Radiation Oncology|February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservationW Zambare, R Ravella, C Li, et al.
Archives of Pathology & Laboratory Medicine|March 9, 2025
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/NeoplasmsSavanah D Gisriel, Fnu Aakash, John M Bennett, et al.
The Lancet. Haematology|November 1, 2023
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation studyThomas Pabst, Cristina Papayannidis, Fatih Demirkan, et al.
Biomaterials Science|February 2, 2016
A nanopatterned cell-seeded cardiac patch prevents electro-uncoupling and improves the therapeutic efficacy of cardiac repairYi-Dong Lin, Ming-Chin Ko, Su-Ting Wu, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Blood|October 11, 2022
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemiaDonia M Moujalled, Fiona C Brown, Chong Chyn Chua, et al.
Leukemia|September 15, 2018
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaDonia M Moujalled, Giovanna Pomilio, Corina Ghiurau, et al.
Pageof 172